Overview

Genotyping Influences Outcome of Coronary Artery Stenting

Status:
Completed
Trial end date:
2016-02-01
Target enrollment:
0
Participant gender:
All
Summary
This study evaluated epidemiology and clinical outcome of clopidogrel related various genotyping in Korean patients who had undergone percutaneous coronary intervention as a all comer registry form.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Korea University Anam Hospital
Treatments:
Clopidogrel
Ticlopidine
Criteria
Inclusion Criteria:

- Written informed consent

- Older than 20 years

- All percutaneous coronary intervention patients within 1 month

Exclusion Criteria:

- Pregnancy

- Life expectancy below 1 year

- Known aspirin or clopidogrel allergy